Related references
Note: Only part of the references are listed.Matrix metalloproteinase 9 (MMP9) level and MMP9-1562C > T in patients with obstructive sleep apnea: a systematic review and meta-analysis of case-control studies
Xiaolian Fang et al.
SLEEP MEDICINE (2020)
Multiple biomarkers covering several pathways improve predictive ability for cognitive impairment among ischemic stroke patients with elevated blood pressure
Zhengbao Zhu et al.
ATHEROSCLEROSIS (2019)
Association between matrix metalloproteinase family gene polymorphisms and risk of ischemic stroke: A systematic review and meta-analysis of 29 studies
Shubham Misra et al.
GENE (2018)
Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population
Hari Vishal Lakhani et al.
PLOS ONE (2018)
Advances in Understanding the Pathophysiology of Lacunar Stroke A Review
Robert W. Regenhardt et al.
JAMA NEUROLOGY (2018)
Chronic intermittent hypoxia-mediated renal sympathetic nerve activation in hypertension and cardiovascular disease
Keiko Takahashi et al.
SCIENTIFIC REPORTS (2018)
MMP-9 and Its Regulators TIMP-1 and EMMPRIN in Patients with Acute ST-Elevation Myocardial Infarction: A NORDISTEMI Substudy
Trine Baur Opstad et al.
CARDIOLOGY (2018)
Crosstalk between obesity and MMP-9 in cardiac remodelling -a cross-sectional study in apparent treatment-resistant hypertension
Alessandra Mileni Versuti Ritter et al.
BLOOD PRESSURE (2017)
Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke
Chongke Zhong et al.
NEUROLOGY (2017)
Distraction Osteogenesis Maxillary Expansion (DOME) for Adult Obstructive Sleep Apnea Patients with High Arched Palate
Stanley Yung-Chuan Liu et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2017)
Association between matrix metalloproteinase-9 and worsening heart failure events in patients with chronic heart failure
Tetsuji Morishita et al.
ESC HEART FAILURE (2017)
Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome
Eugenia Hopps et al.
CLINICAL HEMORHEOLOGY AND MICROCIRCULATION (2016)
Relaxin in Obstructive Sleep Apnea: Relationship with Blood Pressure and Inflammatory Mediators
Anna Bonanno et al.
RESPIRATION (2016)
Do salivary and serum collagenases have a role in an association between obstructive sleep apnea syndrome and periodontal disease? A preliminary case-control study
Nejat Nizam et al.
ARCHIVES OF ORAL BIOLOGY (2015)
Comprehensive biomarker profiling in patients with obstructive sleep apnea
Micha T. Maeder et al.
CLINICAL BIOCHEMISTRY (2015)
Sleep Disordered Breathing and Academic Performance: A Meta-analysis
Barbara Galland et al.
PEDIATRICS (2015)
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Lalita Yadav et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Changes in serum levels of MDA and MMP-9 after UPF in patients with OSAS
Erkan Vuralkan et al.
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2014)
Increased C-C Chemokine Receptor 2 Gene Expression in Monocytes of Severe Obstructive Sleep Apnea Patients and under Intermittent Hypoxia
Li-Pang Chuang et al.
PLOS ONE (2014)
Increased Prevalence of Sleep-Disordered Breathing in Adults
Paul E. Peppard et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis
Chiara Marchesi et al.
JOURNAL OF HYPERTENSION (2012)
Cerebrovascular Consequences of Obstructive Sleep Apnea
David J. Durgan et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation
Erin M. Bekes et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure?
Patrick Collier et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis
Junhong Wang et al.
HEART (2011)
Biochemical oxidative stress-related markers in patients with obstructive sleep apnea
Jana Volna et al.
MEDICAL SCIENCE MONITOR (2011)
Circulating Matrix Metalloproteinase-3 and Metalloproteinase-9 and Tissue Doppler Measures of Diastolic Dysfunction to Risk Stratify Patients With Systolic Heart Failure
Simona Buralli et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Obstructive Sleep Apnea-Hypopnea and Incident Stroke The Sleep Heart Health Study
Susan Redline et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Plasma matrix metalloproteinase-9 better predicts outcome than N-terminal protype-B natriuretic peptide in patients with systolic heart failure and a high prevalence of coronary artery disease
Frank Lloyd Dini et al.
BIOMEDICINE & PHARMACOTHERAPY (2010)
Interactions Between Obesity and Obstructive Sleep Apnea Implications for Treatment
Abel Romero-Corral et al.
CHEST (2010)
Myocardial remodeling after infarction: the role of myofibroblasts
Susanne W. M. van den Borne et al.
NATURE REVIEWS CARDIOLOGY (2010)
Matrix Metalloproteinases: Discrete Elevations in Essential Hypertension and Hypertensive End-Stage Renal Disease
Ryan S. Friese et al.
CLINICAL AND EXPERIMENTAL HYPERTENSION (2009)
Multiple Roles of the Extracellular Matrix in Inflammation
E. Korpos et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Serum levels of large tenascin-C variants, matrix metalloproteinase-9, and tissue inhibitors of matrix metalloproteinases in concentric versus eccentric left ventricular hypertrophy
Marcus Franz et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment
Ibrahim Koral Onal et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2009)
Production of Inflammatory Mediators by Monocytes in Patients with Obstructive Sleep Apnea Syndrome
Shinji Tamaki et al.
INTERNAL MEDICINE (2009)
Obstructive Sleep Apnea: A Risk Factor for Work Disability
Theodore A. Omachi et al.
SLEEP (2009)
Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes
Andrew C. Newby et al.
THROMBOSIS AND HAEMOSTASIS (2009)
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction
Dominic Kelly et al.
EUROPEAN HEART JOURNAL (2008)
High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA
Octavio Moldes et al.
STROKE (2008)
Latent MMP-9 is bound to TIMP-1 before secretion
Martin Roderfeld et al.
BIOLOGICAL CHEMISTRY (2007)
Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension
Jing Tan et al.
HYPERTENSION RESEARCH (2007)
Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome
Ye Jin et al.
CHINESE MEDICAL JOURNAL (2007)
Different roles of matrix metalloproteinases-2 and-9 after human ischaemic stroke
V. Lucivero et al.
NEUROLOGICAL SCIENCES (2007)
Matrix metalloproteinases (MMPs): Chemical-biological functions and (Q)SARs
Rajeshwar P. Verma et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Diastolic heart failure - Evidence of increased myocardial collagen turnover linked to diastolic dysfunction
Ramon Martos et al.
CIRCULATION (2007)
New-onset hypertension and inflammatory response/poor outcome in acute ischemic stroke
M. Rodriguez-Yanez et al.
NEUROLOGY (2006)
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction
Rupak Mukherjee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure
Andrew T. Yan et al.
JOURNAL OF CARDIAC FAILURE (2006)
Matrix metalloproteinases/tissue inhibitors of metalloproteinases - Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease
SH Ahmed et al.
CIRCULATION (2006)
Pulmonary hypertension in obstructive sleep apnoea:: effects of continuous positive airway pressure -: A randomized, controlled cross-over study
MA Arias et al.
EUROPEAN HEART JOURNAL (2006)
Matrix metalloproteinase-2,-9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension
Giuseppe Derosa et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2006)
Contribution of plasma matrix metalloproteinases to development of left ventricular hypertrophy and diastolic dysfunction in hypertensive subjects
M Saglam et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions - A study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloproteinase inducer glycosylation forms
JPG Sluijter et al.
STROKE (2006)
Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure
J George et al.
AMERICAN HEART JOURNAL (2005)
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke
A Rosell et al.
STROKE (2005)
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
JM Marin et al.
LANCET (2005)
Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness
Yasmin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling
S Lehoux et al.
CIRCULATION (2004)
The effect of Ca2+ channel antagonists on plasma concentrations of matrix metalloproteinase-2 and-9 in essential hypertension
A Zervoudaki et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients
A Ergul et al.
AMERICAN JOURNAL OF HYPERTENSION (2004)
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction
IB Squire et al.
JOURNAL OF CARDIAC FAILURE (2004)
Increased levels and activity of matrix metal loproteinase-9 in obstructive sleep apnea syndrome
T Tazaki et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Association of atrial fibrillation and obstructive sleep apnea
AS Gami et al.
CIRCULATION (2004)
Early biomarkers of stroke
MA Reynolds et al.
CLINICAL CHEMISTRY (2003)
Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients - Influence of different therapies
S Horstmann et al.
STROKE (2003)
Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure
JH Heo et al.
STROKE (2003)
Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction
S Frantz et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2003)
Plasma levels of active extracellular matrix metalloproteinases 2 and 9 in patients with essential hypertension before and after anti hypertensive treatment
A Zervoudaki et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke
M Castellanos et al.
STROKE (2003)
Cardiac remodelling in end stage heart failure:: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP
D Reinhardt et al.
HEART (2002)
Matrix metalloproteinase inhibition after myocardial infarction - A new approach to prevent heart failure?
EEJM Creemers et al.
CIRCULATION RESEARCH (2001)
Matrix metalloproteinase expression after human cardioembolic stroke -: Temporal profile and relation to neurological impairment
J Montaner et al.
STROKE (2001)
The relationship between craniofacial morphology and obstructive sleep apnea in whites and in African-Americans
B Cakirer et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the sleep heart health study
E Shahar et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy
FL Li-Saw-Hee et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2000)
Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study
FJ Nieto et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition
H Li et al.
CARDIOVASCULAR RESEARCH (2000)
Tissue inhibitors of metalloproteinases: evolution, structure and function
K Brew et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2000)
Share Paper
